1921
Volume 98, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Visceral leishmaniasis, a neglected tropical disease, is the third most common opportunistic disease in immunosuppressed patients, such as those affected by the human immunodeficiency virus (HIV)/acquired immune deficiency syndrome. Although the reports have been characterized as /HIV coinfections, the occurrence of a mixed infection by two species in HIV-positive patients is rare. Here, we present an atypical case of disseminated cutaneous leishmaniasis (DCL) in a 26-year-old HIV-positive man. The diagnosis of DCL was established using skin biopsy and histopathology examinations and confirmed by molecular techniques. This is the first case of a /HIV coinfection due to a mixed infection of / in Iran.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.17-0490
2017-11-20
2019-07-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/98/1/tpmd170490.html?itemId=/content/journals/10.4269/ajtmh.17-0490&mimeType=html&fmt=ahah

References

  1. Mohebali M, , 2013. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol 8: 348358. [Google Scholar]
  2. Badirzadeh A, Taheri T, Taslimi Y, Abdossamadi Z, Heidari-Kharaji M, Gholami E, Sedaghat B, Niyyati M, Rafati S, , 2017. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites. PLoS Negl Trop Dis 11: e0005774. [Google Scholar]
  3. Badirzadeh A, Mohebali M, Asadgol Z, Soong L, Zeinali M, Mokhayeri Y, Shirzadi MR, Spotin A, , 2017. The burden of leishmaniasis in Iran, acquired from the global burden of disease during 1990–2010. Asian Pac J Trop Dis 7: 513518. [Google Scholar]
  4. Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Badirzadeh A, Rafati S, , 2016. Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model. Parasite Immunol 38: 599608. [Google Scholar]
  5. Montakhab-Yeganeh H, Abdossamadi Z, Zahedifard F, Taslimi Y, Badirzadeh A, Saljoughian N, Taheri T, Taghikhani M, Rafati S, , 2017. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice. Parasite Immunol 39: e12461. [Google Scholar]
  6. Badirzadeh A, Mohebali M, Ghasemian M, Amini H, Zarei Z, Akhoundi B, Hajjaran H, Emdadi D, Molaei S, Kusha A, , 2013. Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002–2011: a case series. Pathog Glob Health 107: 194197. [Google Scholar]
  7. Jafari S, Hajiabdolbaghi M, Mohebali M, Hajjaran H, Hashemian H, , 2010. Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran. East Mediterr Health 16: 340343. [Google Scholar]
  8. Pourahmad M, Hooshmand F, Rahiminejad M, , 2009. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). Int J Dermatol 48: 5961. [Google Scholar]
  9. Parmentier L, 2016. Severe cutaneous leishmaniasis in a human immunodeficiency virus patient coinfected with Leishmania braziliensis and its endosymbiotic virus. Am J Trop Med Hyg 94: 840843. [Google Scholar]
  10. Davarpanah M, Rassaei M, , 2015. Presentation of AIDS with disseminated cutaneous and visceral leishmaniasis in Iran. Case Rep Infect Dis 2015: 563851. [Google Scholar]
  11. Kazemi-Rad E, Mohebali M, Hajjaran H, Rezaei S, Mamishi S, , 2008. Diagnosis and characterization of Leishmania species in Giemsa-stained slides by PCR-RFLP. Iran J Public Health 37: 5460. [Google Scholar]
  12. Badirzadeh A, Taheri T, Abedi-Astaneh F, Taslimi Y, Abdossamadi Z, Montakhab-Yeganeh H, Aghashahi M, Niyyati M, Rafati S, , 2017. Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis. Parasite Immunol 39: e12454. [Google Scholar]
  13. Calvopina M, Aguirre C, Cevallos W, Castillo A, Abbasi I, Warburg A, , 2017. Coinfection of Leishmania guyanensis and human immunodeficiency virus-acquired immune deficiency syndrome: report of a case of disseminated cutaneous leishmaniasis in Ecuador. Am J Trop Med Hyg 96: 11511154. [Google Scholar]
  14. Shafiei R, Mohebali M, Akhoundi B, Galian MS, Kalantar F, Ashkan S, Fata A, Farash BRH, Ghasemian M, , 2014. Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study. Travel Med Infect Dis 12: 173178. [Google Scholar]
  15. Calza L, D’antuono A, Marinacci G, Manfredi R, Colangeli V, Passarini B, Orioli R, Varoli O, Chiodo F, , 2004. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS. J Am Acad Dermatol 50: 461465. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0490
Loading
/content/journals/10.4269/ajtmh.17-0490
Loading

Data & Media loading...

  • Received : 20 Jun 2017
  • Accepted : 04 Oct 2017
  • Published online : 20 Nov 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error